283 related articles for article (PubMed ID: 9242546)
21. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor.
Pemberton AD; Huntley JF; Miller HR
Biochim Biophys Acta; 1998 Jan; 1379(1):29-34. PubMed ID: 9468329
[TBL] [Abstract][Full Text] [Related]
22. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
Rao NV; Marshall BC; Gray BH; Hoidal JR
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
[TBL] [Abstract][Full Text] [Related]
23. Endogenous mucosal antiviral factors of the oral cavity.
Shugars DC
J Infect Dis; 1999 May; 179 Suppl 3():S431-5. PubMed ID: 10099113
[TBL] [Abstract][Full Text] [Related]
24. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
[TBL] [Abstract][Full Text] [Related]
25. Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function.
Yang J; Zhu J; Sun D; Ding A
Biochim Biophys Acta; 2005 Sep; 1745(3):310-7. PubMed ID: 16112212
[TBL] [Abstract][Full Text] [Related]
26. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.
Sathe S; Sakata M; Beaton AR; Sack RA
Curr Eye Res; 1998 Apr; 17(4):348-62. PubMed ID: 9561826
[TBL] [Abstract][Full Text] [Related]
27. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
[TBL] [Abstract][Full Text] [Related]
28. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
[TBL] [Abstract][Full Text] [Related]
29. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.
Baqui AA; Meiller TF; Falkler WA
Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568
[TBL] [Abstract][Full Text] [Related]
30. Glycosaminoglycans regulate elastase inhibition by oxidized secretory leukoprotease inhibitor.
Ying QL; Kemme M; Saunders D; Simon SR
Am J Physiol; 1997 Mar; 272(3 Pt 1):L533-41. PubMed ID: 9124611
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement.
Tseng CC; Tseng CP
FEBS Lett; 2000 Jun; 475(3):232-6. PubMed ID: 10869562
[TBL] [Abstract][Full Text] [Related]
32. Interactions between the megakaryocyte/platelet-specific beta1 tubulin and the secretory leukocyte protease inhibitor SLPI suggest a role for regulated proteolysis in platelet functions.
Schulze H; Korpal M; Bergmeier W; Italiano JE; Wahl SM; Shivdasani RA
Blood; 2004 Dec; 104(13):3949-57. PubMed ID: 15315966
[TBL] [Abstract][Full Text] [Related]
33. Secretory leukocyte protease inhibitor, but not alpha-1 protease inhibitor, blocks tryptase-induced bronchoconstriction.
Forteza RM; Ahmed A; Lee T; Abraham WM
Pulm Pharmacol Ther; 2001; 14(2):107-10. PubMed ID: 11273791
[TBL] [Abstract][Full Text] [Related]
34. The role of the oral environment in HIV-1 transmission.
Shugars DC; Wahl SM
J Am Dent Assoc; 1998 Jul; 129(7):851-8. PubMed ID: 9685760
[TBL] [Abstract][Full Text] [Related]
35. Localisation of secretory leucocyte proteinase inhibitor mRNA in nasal mucosa.
Westin U; Fryksmark U; Polling A; Ohlsson K
Acta Otolaryngol; 1994 Mar; 114(2):199-202. PubMed ID: 7515550
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis.
Ohlsson S; Falk R; Yang JJ; Ohlsson K; Segelmark M; Wieslander J
Clin Exp Immunol; 2003 Jan; 131(1):190-6. PubMed ID: 12519404
[TBL] [Abstract][Full Text] [Related]
37. Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells.
Si-Tahar M; Merlin D; Sitaraman S; Madara JL
Gastroenterology; 2000 Jun; 118(6):1061-71. PubMed ID: 10833481
[TBL] [Abstract][Full Text] [Related]
38. Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts.
Kikuchi T; Abe T; Yaekashiwa M; Tominaga Y; Mitsuhashi H; Satoh K; Nakamura T; Nukiwa T
Am J Respir Cell Mol Biol; 2000 Sep; 23(3):364-70. PubMed ID: 10970828
[TBL] [Abstract][Full Text] [Related]
39. The expression of secretory leukocyte protease inhibitor (SLPI) in the fallopian tube: SLPI protects the acrosome reaction of sperm from inhibitory effects of elastase.
Ota Y; Shimoya K; Zhang Q; Moriyama A; Chin R; Tenma K; Kimura T; Koyama M; Azuma C; Murata Y
Hum Reprod; 2002 Oct; 17(10):2517-22. PubMed ID: 12351521
[TBL] [Abstract][Full Text] [Related]
40. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
Taggart CC; Cryan SA; Weldon S; Gibbons A; Greene CM; Kelly E; Low TB; O'neill SJ; McElvaney NG
J Exp Med; 2005 Dec; 202(12):1659-68. PubMed ID: 16352738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
